Variant-specific symptoms of COVID-19 in a study of 1,542,510 adults in England. (2022)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-34244-2
PubMed Identifier: 36369151
Publication URI: http://europepmc.org/abstract/MED/36369151
Type: Journal Article/Review
Volume: 13
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723